Your browser doesn't support javascript.
loading
Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study.
Bousquet, J; Caimmi, D P; Bedbrook, A; Bewick, M; Hellings, P W; Devillier, P; Arnavielhe, S; Bachert, C; Bergmann, K C; Canonica, G W; Chavannes, N H; Cruz, A A; Dahl, R; Demoly, P; De Vries, G; Mathieu-Dupas, E; Finkwagner, A; Fonseca, J; Guldemond, N; Haahtela, T; Hellqvist-Dahl, B; Just, J; Keil, T; Klimek, L; Kowalski, M L; Kuitunen, M; Kuna, P; Kvedariene, V; Laune, D; Pereira, A M; Carreiro-Martins, P; Melén, E; Morais-Almeida, M; Mullol, J; Muraro, A; Murray, R; Nogueira-Silva, L; Papadopoulos, N G; Passalacqua, G; Portejoie, F; Price, D; Ryan, D; Samolinski, B; Sheikh, A; Siroux, V; Spranger, O; Todo Bom, A; Tomazic, P V; Valero, A; Valovirta, E.
Afiliación
  • Bousquet J; MACVIA-LR, Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon, European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.
  • Caimmi DP; INSERM, VIMA: Ageing and Chronic Diseases Epidemiological and Public Health Approaches, U1168 Paris, and UVSQ, UMR-S 1168, Université Versailles St-Quentin-en-Yvelines, Yvelines, France.
  • Bedbrook A; CHRU de Montpellier, UPMC Paris 06, UMR-S 1136, IPLESP, Equipe EPAR, Sorbonne Universités, Paris, France.
  • Bewick M; Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France.
  • Hellings PW; MACVIA-LR, Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon, European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.
  • Devillier P; iQ4U Consultants Ltd, London, UK.
  • Arnavielhe S; Department of Microbiology and Immunology, Laboratory of Clinical Immunology, KU Leuven, Leuven, Belgium.
  • Bachert C; Laboratoire de Pharmacologie Respiratoire UPRES EA220, Pôle des Maladies Respiratoires, Hôpital Foch, Suresnes Université Versailles Saint-Quentin, Versailles, France.
  • Bergmann KC; Kyomed, Montpellier, France.
  • Canonica GW; ENT Department, Upper Airways Research Laboratory, Ghent University Hospital, Ghent, Belgium.
  • Chavannes NH; Department of Dermatology and Allergy, Comprehensive Allergy-Centre-Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Cruz AA; Global Allergy and Asthma European Network (GA2LEN), Berlin, Germany.
  • Dahl R; Allergy and Respiratory Diseases Clinic, DIMI, University of Genoa, IRCCS AOU San Martino-IST, Genoa, Italy.
  • Demoly P; Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
  • De Vries G; ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Salvador, Brasil.
  • Mathieu-Dupas E; GARD Executive Committee, Geneva, Switzerland.
  • Finkwagner A; ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Salvador, Brasil.
  • Fonseca J; GARD Executive Committee, Geneva, Switzerland.
  • Guldemond N; CHRU de Montpellier, UPMC Paris 06, UMR-S 1136, IPLESP, Equipe EPAR, Sorbonne Universités, Paris, France.
  • Haahtela T; Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France.
  • Hellqvist-Dahl B; Peercode BV, Gerdermalsen, The Netherlands.
  • Just J; Kyomed, Montpellier, France.
  • Keil T; Global Allergy and Asthma Platform GAAPP, Vienna, Austria.
  • Klimek L; Center for Health Technology and Services Research - CINTESIS, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
  • Kowalski ML; Allergy Unit, CUF Porto Instituto & Hospital, Porto, Portugal.
  • Kuitunen M; Institute of Health Policy and Management iBMG - Erasmus Universit, Rotterdam, The Netherlands.
  • Kuna P; Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
  • Kvedariene V; Department of Respiratory Diseases, Odense University Hospital, Odense, Denmark.
  • Laune D; Allergology Department, Centre de l'Asthme et des Allergies Hôpital d'Enfants Armand-Trousseau (APHP), UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe EPAR, Sorbonne Universités, Paris, France.
  • Pereira AM; Institute of Social Medicine, Epidemiology and Health Economics, Charité -Universitätsmedizin Berlin, Berlin, Germany.
  • Carreiro-Martins P; Institute for Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany.
  • Melén E; Center for Rhinology and Allergology, Wiesbaden, Germany.
  • Morais-Almeida M; Department of Immunology, Rheumatology and Allergy, Healthy Ageing Reseach Centre (HARC), Medical University of Lodz, Lodz, Poland.
  • Mullol J; Children's Hospital, University of Helsinki and University Hospital of Helsinki, Helsinki, Finland.
  • Muraro A; Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
  • Murray R; Clinic of Infectious, Chest Diseases, Dermatology and Allergology, Vilnius University, Vilnius, Lithuania.
  • Nogueira-Silva L; Kyomed, Montpellier, France.
  • Papadopoulos NG; Center for Health Technology and Services Research - CINTESIS, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
  • Passalacqua G; Allergy Unit, CUF Porto Instituto & Hospital, Porto, Portugal.
  • Portejoie F; CEDOC, Respiratory Research Group, Nova Medical School, Campo dos Martires da Patria, Lisbon, Portugal.
  • Price D; Serviço de Imunoalergologia, Hospital de Dona Estefânia, Centro Hospitalar de Lisboa Central, EPE, Lisbon, Portugal.
  • Ryan D; Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.
  • Samolinski B; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Sheikh A; Allergy and Clinical Immunology Department, Hospital CUF-Descobertas, Lisboa, Portugal.
  • Siroux V; ENT Department, Hospital Clinic, Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, Universitat de Barcelona, Barcelona, Catalonia, Spain.
  • Spranger O; Department of Women and Child Health, Food Allergy Referral Centre Veneto Region, Padua General University Hospital, Padua, Italy.
  • Todo Bom A; Medical Communications Consultant, MedScript Ltd, Dundalk, Co Louth, Ireland.
  • Tomazic PV; Center for Health Technology and Services Research - CINTESIS, Porto, Portugal.
  • Valero A; Department of Internal Medicine, Centro Hospitalar Sao Joao, Porto, Portugal.
  • Valovirta E; Center for Pediatrics and Child Health, Institute of Human Development, Royal Manchester Children's Hospital, University of Manchester, Manchester, UK.
Allergy ; 72(6): 857-865, 2017 Jun.
Article en En | MEDLINE | ID: mdl-28072463
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Teléfono Celular / Rinitis Alérgica Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Allergy Año: 2017 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Teléfono Celular / Rinitis Alérgica Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Allergy Año: 2017 Tipo del documento: Article País de afiliación: Francia